Question

Is stem cell therapy for ALS (Motor Neurone Disease) covered by insurance?

Reimbursement from insurers and government health systems is absent. Clinical trials provide treatment at no cost to enrolled participants. ALS Association (USA) and international ALS federations maintain grants for trial participation; cost assistance is limited. Out-of-pocket financing is the barrier for most non-trial seekers; some centres offer international patient discounting.

The cost picture for ALS (Motor Neurone Disease)

ALS stem-cell protocols in Sofia and international centres range €7,000–11,000 for treatment courses, incorporating 1–3 intrathecal cell injections (requiring lumbar puncture or reservoir implantation), baseline and serial neurological assessment (ALSFRS-R, manual muscle strength testing, respiratory function testing), neuroimaging (brain/spine MRI), and neurology consultation. Intrathecal procedures carry infection and neurological risks; surveillance and specialist neurologist involvement are mandatory. Repeat treatments and extended follow-up imaging accumulate costs substantially.

Am I a candidate? → · ALS (Motor Neurone Disease): full overview → · ALS (Motor Neurone Disease) cost → · Cost →

Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.

Compare stem-cell therapy by country, cost and evidence — in one place.

StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.

Get an honest assessment